ISI International Strategy & Investment

Health Care

Mark Schoenebaum, MD
Mark Schoenebaum, MD

Senior Managing Director
Biotechnology & Pharmaceuticals-Major Analyst
Head of Health Care Research
ISI’s Health Care Team

L to R Back Row: Salim Syed, Wesley Nurss
Mark Schoenebaum, Odysseas Kostas

L to R Front Row: Umer Raffat, Natasha Yeung

Coverage Universe

ACOR

AMGN

BIIB

BMY


CELG

DNDN

GILD

LLY


MDCO

MRK

PFE

UTHR


VRTX

ZTS

 

 

ISI’s Health Care Research Team, headed by Mark Schoenebaum, focuses on providing actionable investment ideas and proprietary research on Biotechnology, Pharmaceutical, and Specialty Pharmaceutical stocks.

Mark has been conducting research on biotechnology companies for more than 13 years. Mark and his team provide clients with an investment edge through “data tidbits” and “on-the-fly” analysis in response to breaking news. They also provide "deep-dive" analyses on clinical, financial, and market data.

The Health Care Research Team is available around the clock, conducts customized client projects, assists with corporate access, and accepts personal meetings.